Search Results 531-540 of 16952 for ketamine
This first-in-human, double-blind, placebo-controlled Phase I study will be conducted in participants with amyotrophic lateral sclerosis (ALS) to explore safety ...
Each person's genetic code is unique. Researchers focused on pharmacogenomics at Mayo Clinic are working to understand how these tiny DNA variations cause ...
About this study. This phase III trial compares memantine to usual treatment in treating patients with brain tumors that are newly diagnosed or has come ...
The purpose of this study is to assess the effect of vedolizumab subcutaneous (vedolizumab SC) as maintenance treatment in participants with moderately to ...
About this study. The goal of this study is to examine the current and (potential) future therapeutic relevance of PGx testing for a group of patients in ...
This study is to evaluate the safety and efficacy of simtuzumab (GS-6624) in adults with compensated cirrhosis due to Non-Alcoholic Steatohepatitis (NASH). It ...
Share · Tweet . IMG-20480077. Home; cc-yoga-cobra_tablet. Fuel groundbreaking medical research! Give Today. Your donation powers the future of medicine and ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
SSRIs and SNRIs raise serotonin levels. Triptans interact directly with some serotonin receptors in the brain. In theory, taking these medicines together could ...
Mayo Clinic psychiatrists and psychologists are leaders in the clinical care of mental illnesses in people of all ages. They tailor their care to your exact ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.